Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of 57.45 billion. The enterprise value is 65.64 billion.
| Market Cap | 57.45B |
| Enterprise Value | 65.64B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | Apr 29, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 129.20M |
Valuation Ratios
The trailing PE ratio is 18.86 and the forward PE ratio is 12.89.
| PE Ratio | 18.86 |
| Forward PE | 12.89 |
| PS Ratio | 2.49 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 10.09 |
| P/FCF Ratio | 21.78 |
| P/OCF Ratio | 12.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.75, with an EV/FCF ratio of 24.88.
| EV / Earnings | 21.55 |
| EV / Sales | 2.69 |
| EV / EBITDA | 9.75 |
| EV / EBIT | 13.77 |
| EV / FCF | 24.88 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.31 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.48 |
| Debt / FCF | 3.56 |
| Interest Coverage | 17.86 |
Financial Efficiency
Return on equity (ROE) is 9.75% and return on invested capital (ROIC) is 6.79%.
| Return on Equity (ROE) | 9.75% |
| Return on Assets (ROA) | 5.26% |
| Return on Invested Capital (ROIC) | 6.79% |
| Return on Capital Employed (ROCE) | 10.44% |
| Revenue Per Employee | 368,017 |
| Profits Per Employee | 48,652 |
| Employee Count | 59,020 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.43% in the last 52 weeks. The beta is 0.64, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -27.43% |
| 50-Day Moving Average | 26.88 |
| 200-Day Moving Average | 30.60 |
| Relative Strength Index (RSI) | 45.67 |
| Average Volume (20 Days) | 121,522 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of 23.04 billion and earned 3.05 billion in profits. Earnings per share was 7.00.
| Revenue | 23.04B |
| Gross Profit | 13.68B |
| Operating Income | 4.50B |
| Pretax Income | 3.88B |
| Net Income | 3.05B |
| EBITDA | 6.35B |
| EBIT | 4.50B |
| Earnings Per Share (EPS) | 7.00 |
Balance Sheet
The company has 1.75 billion in cash and 9.40 billion in debt, giving a net cash position of -7.65 billion.
| Cash & Cash Equivalents | 1.75B |
| Total Debt | 9.40B |
| Net Cash | -7.65B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 32.32B |
| Book Value Per Share | 74.12 |
| Working Capital | 3.15B |
Cash Flow
In the last 12 months, operating cash flow was 4.44 billion and capital expenditures -1.80 billion, giving a free cash flow of 2.64 billion.
| Operating Cash Flow | 4.44B |
| Capital Expenditures | -1.80B |
| Free Cash Flow | 2.64B |
| FCF Per Share | n/a |
Margins
Gross margin is 59.39%, with operating and profit margins of 19.53% and 13.22%.
| Gross Margin | 59.39% |
| Operating Margin | 19.53% |
| Pretax Margin | 16.86% |
| Profit Margin | 13.22% |
| EBITDA Margin | 27.57% |
| EBIT Margin | 19.53% |
| FCF Margin | 11.45% |
Dividends & Yields
This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 1.27%.
| Dividend Per Share | 0.34 |
| Dividend Yield | 1.27% |
| Dividend Growth (YoY) | 6.91% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.37% |
| Buyback Yield | -0.14% |
| Shareholder Yield | 1.14% |
| Earnings Yield | 5.30% |
| FCF Yield | 4.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 15, 2017. It was a forward split with a ratio of 1.6667.
| Last Split Date | Aug 15, 2017 |
| Split Type | Forward |
| Split Ratio | 1.6667 |
Scores
Merck KGaA has an Altman Z-Score of 3.48.
| Altman Z-Score | 3.48 |
| Piotroski F-Score | n/a |